Cadent Therapeutics
Cambridge
About Cadent Therapeutics
Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, and novel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders. It was founded in 2010 and headquartered in Cambridge, Massachusetts.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $66.7M
- Funding stage: M&A
- Last round: Series B (Apr 2020)
- Website: cadenttx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical Device, Neuroscience, Therapeutics, Wellness
Social Profiles
Canonical: https://fsome.com/organization/cadent-therapeutics-95433 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.